CorMedix Company Description

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure.

The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007.

CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

CorMedix Inc.

Country	United States
Founded	2006
Industry	Pharmaceutical Preparations
Employees	65
CEO	Joseph Todisco

Contact Details

Address: 300 Connell Drive Berkeley Heights, Delaware 07922 United States
Phone	908 517 9500
Website	cormedix.com

Stock Details

Ticker Symbol	19KA
Exchange	Frankfurt Stock Exchange
Stock Type	Common Stock
Share Class	Class A Shares
Fiscal Year	January - December
Reporting Currency	USD
SIC Code	2834

Key Executives

Name	Position
Joseph Todisco	Chief Executive Officer
Susan Blum	Chief Financial Officer
Elizabeth Masson-Hurlburt	Chief Operating Officer